Oppenheimer & Co. Inc. Sells 5,376 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN)
Oppenheimer & Co. Inc. lowered its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 13.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,715 shares of the company’s stock after selling 5,376 shares during the quarter. Oppenheimer […]
